This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Oct;3(10):532-3.

doi: 10.1038/ncpcardio0680.

Is elevated cardiovascular risk a class effect of cyclo-oxygenase 2 inhibitors?

Scott D Solomon¹

Affiliations

PMID: 16990835
DOI: 10.1038/ncpcardio0680

Comment

Is elevated cardiovascular risk a class effect of cyclo-oxygenase 2 inhibitors?

Scott D Solomon. Nat Clin Pract Cardiovasc Med. 2006 Oct.

. 2006 Oct;3(10):532-3.

doi: 10.1038/ncpcardio0680.

Author

Scott D Solomon¹

Affiliation

¹ Harvard Medical School, Boston, MA, USA. sdsolomon@bics.bwh.harvard.edu

PMID: 16990835
DOI: 10.1038/ncpcardio0680

No abstract available

PubMed Disclaimer

Comment on

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.
Andersohn F, Suissa S, Garbe E. Andersohn F, et al. Circulation. 2006 Apr 25;113(16):1950-7. doi: 10.1161/CIRCULATIONAHA.105.602425. Epub 2006 Apr 17. Circulation. 2006. PMID: 16618816

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.